Workflow
Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings
TXG10x Genomics(TXG) Zacks Investment Research·2024-02-16 00:01

10x Genomics (TXG) reported 183.98millioninrevenueforthequarterendedDecember2023,representingayear−over−yearincreaseof17.8183.98 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 17.8%. EPS of -0.41 for the same period compares to -0.15ayearago.Thereportedrevenuerepresentsasurpriseof+0.030.15 a year ago.The reported revenue represents a surprise of +0.03% over the Zacks Consensus Estimate of 183.93 million. With the consensus EPS estimate being -$0.36, the EPS surprise was -13.89%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to W ...